Wholly owned subsidiary of King Pharmaceuticals that develops, manufactures and markets therapies and technologies primarily in the therapeutic areas of cardiovascular/metabolics, neuroscience and hospital/acute care.
Address:
501 Fifth St. Bristol, Tennessee 37620 United States
Post new comment